Showing 8,821 - 8,840 results of 48,899 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((greatest decrease) OR (largest decrease)) ))', query time: 0.83s Refine Results
  1. 8821

    Posterior means of movement-rate distributions with respect to the temporal resolution of modelled trajectories. by Claire M. Postlethwaite (410037)

    Published 2013
    “…<p>The figures show the posterior means of the Weibull distributions for movement rates (in m/s), with error bars of one posterior standard deviation, for each of the four possums, as a function of sub-sampling interval. …”
  2. 8822
  3. 8823
  4. 8824
  5. 8825
  6. 8826

    Dendritic Silica Nanospheres with Au–Pt Nanoparticles as Nanozymes for Label-Free Colorimetric Hg<sup>2+</sup> Detection by Jiaojiao Zhou (432827)

    Published 2022
    “…The detection limit was 8.58 pM with a linear range from 0.1 nM to 10 μM. Selectivity toward Hg<sup>2+</sup> has also been demonstrated in aqueous solutions in the presence of other metal ions. …”
  7. 8827
  8. 8828
  9. 8829
  10. 8830
  11. 8831
  12. 8832
  13. 8833
  14. 8834
  15. 8835
  16. 8836

    Decrease in Akt/mTOR signaling and cell proliferation in <i>Tgfbr1/Pten</i> 2cKO ASCC after rapamycin treatment. by Zhi-Jun Sun (467107)

    Published 2013
    “…(B), quantification of staining by histoscores shows a significant decrease in p-Akt, p-S6, and Ki67. …”
  17. 8837
  18. 8838
  19. 8839
  20. 8840

    Rabbit ATG and alemtuzumab decrease effector mechanisms of peripheral blood CD3<sup>−</sup>CD56<sup>dim</sup> NK cells. by Diana Stauch (266579)

    Published 2009
    “…<p>(A) Dose-dependent decrease of NK cell cytotoxicity after 18 hours pretreatment with rATG, alemtuzumab, daclizumab and rIgG (0–100 µg). …”